Acute gliclazide administration enhances glucose and ketone body utilization in the perfused hind limb of normal and streptozotocin-diabetic rats

Life Sciences

Volumn 71, Issue 6, 2002, Pages 647-654

  Okuda, Y ^a   Kobayashi, K ^a   Ohmori, H ^a   Sone, H ^a   Suzuki, S ^a   Ma, J ^a   Nakajima, T ^b   Yamada, N ^a   Yamashita, K ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tsukuba Memorial Hospital   (Japan)

Author keywords

Gliclazide; Ketone body; Rat hind limb perfusion; Streptozotocin diabetic rats; Sulfonylurea

Indexed keywords

3 OXOACID COENZYME A TRANSFERASE; 6 PHOSPHOFRUCTOKINASE; GLICLAZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; KETOGENESIS; LIMB PERFUSION; MALE; NONHUMAN; OXIDATION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FASTING; GLICLAZIDE; GLUCOSE; HINDLIMB; HYPOGLYCEMIC AGENTS; KETONE BODIES; MALE; PERFUSION; RATS; RATS, WISTAR; REFERENCE VALUES; TIME FACTORS;

EID: 0037189092     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01735-6     Document Type: Article

References (10)

1. + channel dependent mechanism
2. Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects
3. Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control
4. Tolbutamide inhibits ketogenesis
5. Ketone Body Utilization and its metabolic effect in resting muscle or normal and streptozotocin-diabetic rat
6. Hormone regulation of glucose metabolism in the genetically obese-diabetic mouse (db/db): Glucose metabolism in the perfused hindquarters of lean and obese mice
7. Sensitive and simplified method for the differential determination of serum levels of ketone bodies
8. Gliclazide
9. Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action
10. Regulation of muscle fructose-2,6-bisphosphate levels by sulfonylureas